-
GABA-A Receptor Positive Allosteric Modulators: Phase 2 Proof of Concept Studies of Brexanolone Injection and SAGE-217 in Essential Tremor
-
Gait impairment in Parkinson’s Disease: An [123I]FP-CIT SPECT study
-
Gait in Spinocerebellar Ataxia Type12 (SCA-12)
-
Gait patterns may distinguish Parkinsonian patients with and without mild cognitive impairment: a data mining approach
-
Gamma-glutamyltransferase and the risk of Parkinson’s disease: A National Health Service big data analysis
-
Gastrointestinal disorders in various forms of parkinsonism
-
Gastrointestinal microbiome in Parkinson’s disease in a Bavarian cohort
-
Gastrointestinal symptoms as a risk factor for the appearance of motor fluctuations in patients with advanced Parkinson disease
-
Gastrointestinal symptoms predict cognitive decline in Parkinson’s Disease
-
Gaze – evoked nystagmus in PSP patients: Is it really atiypical? A case series of eight patients
-
GBA and ATP13A mutation and PD: clinical phenotype, eye movements and pathogenic implications
-
GBA mutation: Linking Parkinson’s and Gaucher’s Diseases
-
GBA p.Glu326Lys substitution increases the risk to develop Parkinson’s disease; is it enough to affect disease phenotype?
-
GBA-LRRK2 Parkinson’s Disease: a clinical case
-
GBA1 biomarkers in longitudinal CSF: GCase, Sphingolipids and alpha-synuclein
-
Gender differences for Motor and non motor symptoms in Parkinson’s Disease among Pakistani population
-
Gender differences in Motor symptoms, Non-Motor symptoms and Quality of Life in Parkinson’s disease: COPPADIS-2015 study cohort
-
Gender differences of fatigue characteristics in people with Parkinson’s disease
-
Gender gap in scientific granting competitions in movement disorders – insights from a national Canadian funding agency
-
Gender-dependent improvement in the survival of Parkinson’s disease patients in Finland
-
Gender-specific effects of uric acid on the development of freezing of gait in Parkinson’s disease
-
Gene Expression Profiling of depression in Huntington’s disease
-
Gene panel testing in movement disorders: an efficient approach highlighting overlaps and heterogeneity
-
Generalised Polymyoclonus In a Patient With Central Nervous System Tuberculosis
-
Genetic analysis of DNA methylation and hydroxymethylation genes in Parkinson’s disease
-
Genetic and clinical investigation of young onset dystonia in Korea: What can we learn?
-
Genetic diagnosis of Chorea-acanthocytosis using whole exome sequencing revealed novel VPS13A Gene mutation
-
Genetic markers revealed in dysregulated pathways in ischemic stroke may lead to Parkinson’s disease
-
Genetic panel testing in Parkinson’s disease
-
Genetic polymorphism (rs6971) in translocator protein (TSPO) and its clinical relevance in Parkinson’s disease
-
Genetic study of patients with Parkinson’s disease subjected to second line therapies
-
Genetics and phenotypes of recessive parkinsonism in French and North African populations
-
Genetics of Parkinson’s in India – Young Onset Parkinson’s Disease (GOPI-YOPD) – A Preliminary Demographic profile
-
Genomic variants associated with cognitive impairment in Parkinson’s disease: Ethnicity-specific GWAS
-
Genotype influences circuit compensation in Parkinson’s disease
-
Genotype-Phenotype correlations of Episodic Ataxia (EA). MDSGene Systematic Review
-
Genotype-phenotype relations for the isolated Dystonia Genes TOR1A, THAP1, GNAL, ANO3, KMT2B, PRKRA and HPCA: MDSGene Systematic Review
-
Geste antagoniste in Catalan art – Santiago Rusiñol’s Laughing Girl
-
Ginsenoside Rb1 Prevents MPTP-Induced Changes in Hippocampal Memory via Regulation of the α-Synuclein/PSD-95 Pathway
-
Glabellar tap predicts dopamine transporter deficiency in parkinsonism
-
Global implementation of efficacious voice treatment for Parkinson’s disease: LSVT LOUD in Germany, France and Japan
-
GluRδ2 protein reduction in cerebellar Purkinje cells contributes to the pathogenesis of essential tremor
-
GLYCOPAR – A randomized, placebo-controlled, 2-arm parallel-group superiority phase II study of glycopyrrolate for moderate-to-severe sialorrhea in Parkinson’s disease
-
Glycopyrrolate as inhalation for treating sialorrhea in Parkinson’s Disease
-
Glymphatic system activity in Parkinson’s disease: diffusion tensor image analysis along the perivascular space (DTI‑ALPS)
-
GNAO1 gene mutation: generalized dystonia without epilepsy.
-
Goal setting for botulinum toxin injections: Impact of the Upper Limb International Spasticity (ULIS) programme
-
Gocovri Dose Adjustment in Elderly Parkinson’s Patients at Risk for Renal Impairment: Implications from an Exposure Simulation Model
-
GPi DBS does not affect sensory thresholds in hereditary/idiopathic dystonia
-
Gray Matter Abnormalities in Parkinson’s disease: a Voxel-wise meta-analysis
-
Gray matter atrophy in Parkinson’s disease and freezing of gait assessed using surface-based algorithm – results of an open, longitudinal, single-centre study
-
Gray matter substrates of depression in blepharospasm
-
Grey matter atrophy in Parkinson’s disease with long-duration response
-
Grey-matter volume changes underpinning irritability and aggression in early manifest Huntington’s disease
-
Guided Self-rehabilitation Contracts combined with simultaneous injections of abobotulinumtoxinA into upper and lower limbs in spastic hemiparesis: baseline data from the ENGAGE study
-
Gustatory Connectivity in Parkinson’s Disease Progression
-
Gut Feelings about Parkinson’s Disease: The Influence of the Gut Microbiota in a Rodent Model
-
Gut microbiota in Parkinson disease with mild cognition impairment in a southern Chinese cohort.
-
Gut problems in Huntington’s disease? Evidence for a leaky gut in the R6/2 mouse model of HD
2019 International Congress
September 22-26, 2019. Nice, France.